Dr. Ethan Kellum has been featured on MSN as one of the “Top 7 Experts to Watch in 2026: The best doctors, lawyers, and founders disrupting their industries,” a curated list highlighting leaders who are reshaping how Americans think about health, wealth, justice, and performance.
The feature spotlights professionals across multiple fields who are actively challenging traditional systems and replacing outdated models with more effective, patient-centered, and outcome-driven approaches. Among them is Dr. Ethan Kellum, recognized for his work in regenerative orthopedics and his commitment to advancing non-surgical musculoskeletal care.
A New Class of Industry Leaders Emerging in 2026
The MSN feature outlines a broader shift happening across multiple sectors. From regenerative medicine to legal innovation and financial education, the common thread is disruption of legacy systems that have remained largely unchanged for decades.
In medicine, the traditional approach often defaults to surgery, long-term medication use, or symptom management. In contrast, a growing number of specialists are exploring biologic and regenerative solutions that aim to restore function rather than replace it.
In law, large-scale mass tort litigation is evolving with more coordinated national strategies. In finance and education, alternative wealth-building frameworks are challenging conventional mortgage and investment assumptions. Across every category, the emphasis is shifting toward proactive systems that prioritize long-term outcomes rather than reactive intervention.
Dr. Kellum’s work is highlighted within this context as part of a broader movement toward innovation in clinical practice.
Dr. Ethan Kellum: Redefining Orthopedic Care Through Regenerative Medicine
Based in the Nashville and Franklin, Tennessee area, Dr. Kellum is a sports medicine fellowship-trained orthopedic surgeon with extensive experience treating both elite athletes and everyday patients. His background includes serving as a team physician for the NFL’s Tennessee Titans and USA Basketball, as well as assisting with the NBA’s Boston Celtics during his fellowship at New England Baptist Hospital and Boston Children’s Hospital.
He is also a member of the Alpha Omega Alpha Medical Honor Society and earned his medical degree from the University of Tennessee Health Science Center, reflecting a strong academic and clinical foundation.
While he continues to perform arthroscopic surgical procedures of the shoulder and knee when necessary, his primary focus has shifted toward interventional and regenerative orthopedics. This includes biologic treatments designed to support the body’s natural healing capacity.
These treatments may include platelet-rich plasma (PRP), bone marrow concentrate containing stem cells, A2M therapy, and other advanced image-guided biologic interventions. Rather than relying solely on structural correction through surgery, these approaches aim to reduce inflammation, stimulate tissue repair, and preserve joint integrity.
Bringing Pro-Athlete Medicine to Everyday Patients
One of the defining aspects of Dr. Kellum’s practice is the translation of elite sports medicine protocols into standard patient care.
The same regenerative techniques used to help professional athletes recover from high-impact injuries are applied to patients dealing with chronic joint pain, degenerative conditions, and soft tissue injuries. This includes individuals seeking to avoid or delay joint replacement surgery, reduce reliance on opioids, or maintain long-term mobility.
Patients range widely in age and activity level. A professional athlete recovering from a ligament injury may receive similar biologic principles of care as a 65-year-old patient seeking to return to recreational activities such as golf or pickleball. The underlying goal remains consistent: preserve function, restore movement, and improve quality of life through minimally invasive treatment options.
A Shift Away From “Surgery First” Orthopedics
Historically, orthopedic medicine has been heavily procedural. Surgery has often been the primary intervention for degenerative joint conditions once conservative care options are exhausted.
Dr. Kellum’s approach reflects a growing shift in the field toward earlier intervention with biologic therapies, with the aim of delaying or preventing the need for surgical replacement. In many cases, patients are seeking alternatives that allow them to maintain their native joint for as long as possible.
This philosophy does not eliminate surgery from care pathways when it is necessary, but it does prioritize less invasive options whenever clinically appropriate.
The result is a more layered treatment model that integrates diagnostics, regenerative medicine, rehabilitation, and surgical precision when required.
Why His Work Is Being Recognized in 2026
The MSN feature emphasizes individuals whose work is not only innovative but also responsive to real systemic challenges.
In orthopedics, two of the most pressing issues in the United States are the rising cost and frequency of joint replacement surgeries and the long-term impact of opioid dependency in pain management. Regenerative orthopedics has emerged as one of the most promising areas addressing both concerns.
Dr. Kellum’s inclusion reflects his role in advancing evidence-informed biologic treatments within mainstream orthopedic practice. His focus on preserving joint health rather than defaulting to replacement surgery aligns with broader healthcare trends emphasizing prevention, function, and longevity.
Looking Ahead: The Future of Orthopedic Innovation
As regenerative medicine continues to evolve, the boundary between surgical and non-surgical care is becoming increasingly integrated. Image-guided biologic therapies, improved diagnostic tools, and patient-specific treatment planning are reshaping what orthopedic care can look like over the next decade.
Practitioners like Dr. Kellum represent a growing segment of physicians working at this intersection of traditional surgical expertise and regenerative innovation.
The MSN recognition underscores not only individual achievement, but also a broader shift in patient expectations. Patients are increasingly seeking options that preserve their natural anatomy, reduce downtime, and support long-term health outcomes.
